Skip to main content

Peer Review reports

From: Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online

Original Submission
26 Aug 2016 Submitted Original manuscript
24 Oct 2016 Reviewed Reviewer Report - Jeonghoon Ahn
14 Nov 2016 Reviewed Reviewer Report - Takafumi Katayama
30 Dec 2016 Author responded Author comments - Beate Jahn
Resubmission - Version 2
30 Dec 2016 Submitted Manuscript version 2
21 Jan 2017 Author responded Author comments - Beate Jahn
Resubmission - Version 3
21 Jan 2017 Submitted Manuscript version 3
15 Jun 2017 Author responded Author comments - Beate Jahn
Resubmission - Version 4
15 Jun 2017 Submitted Manuscript version 4
31 Jul 2017 Author responded Author comments - Beate Jahn
Resubmission - Version 5
31 Jul 2017 Submitted Manuscript version 5
20 Aug 2017 Author responded Author comments - Beate Jahn
Resubmission - Version 6
20 Aug 2017 Submitted Manuscript version 6
Publishing
23 Aug 2017 Editorially accepted
16 Oct 2017 Article published 10.1186/s12885-017-3603-z

You can find further information about peer review here.

Back to article page